News
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted marketing authorization ...
The European Commission has granted marketing authorization for Gilead Sciences' twice-yearly injection for preventing HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback